Researchers from Fujian Medical University Report New Studies and Findings in the Area of Cancer (Shcbp1 Is a Prognostic Biomarker Related To the Tumour Immune Microenvironment In Pan-cancer).

Předmět:
Zdroj: Drug Week; 2/24/2023, p783-783, 1p
Abstrakt: For more information on this research see: Shcbp1 Is a Prognostic Biomarker Related To the Tumour Immune Microenvironment In Pan-cancer. Keywords: Fujian; People's Republic of China; Asia; Biomarkers; Cancer; Diagnostics and Screening; Health and Medicine; Oncology; Prognostic Markers EN Fujian People's Republic of China Asia Biomarkers Cancer Diagnostics and Screening Health and Medicine Oncology Prognostic Markers 783 783 1 03/24/23 20230224 NES 230224 2023 FEB 21 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Data detailed on Cancer have been presented. [Extracted from the article]
Databáze: Complementary Index